The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders (AD) or major toxicity with ipilimumab (IPI).
 
Alexander M. Menzies
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Douglas Buckner Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Genoptix
 
Sangeetha Ramanujam
No Relationships to Disclose
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; MSD Oncology; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Novartis
 
Annie N.M. Wong
No Relationships to Disclose
 
John J Park
No Relationships to Disclose
 
Jennifer Leigh McQuade
No Relationships to Disclose
 
Alexander Noor Shoushtari
Consulting or Advisory Role - Vaccinex
Research Funding - Bristol-Myers Squibb (Inst)
 
Katy K. Tsai
No Relationships to Disclose
 
Zeynep Eroglu
No Relationships to Disclose
 
Oliver Klein
Consulting or Advisory Role - MSD Oncology
 
Jessica Cecile Hassel
Honoraria - BMS, MSD, Roche, GSK/Novartis, Amgen
Consulting or Advisory Role - MSD, Amgen
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - BMS, MSD, Amgen, GSK
 
Jeffrey Alan Sosman
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Novartis (Inst)
 
Alex Guminski
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Merck; Novartis; Pfizer
 
Ryan J. Sullivan
Consulting or Advisory Role - Astex Pharmaceuticals; Biodesix; Novartis; Prometheus
Other Relationship - Boehringer Ingelheim
 
Antoni Ribas
Stock and Other Ownership Interests - Arcus Ventures; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Merck
 
Matteo S. Carlino
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD Oncology; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Novartis
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Shahneen Kaur Sandhu
Honoraria - Bristol-Myers Squibb
 
Georgina V. Long
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche/Genentech